Subscribe to RSS - CEO

CEO

Inogen transitions management, expands board

 - 
12/06/2016

GOLETA, Calif. – Inogen will have a new CEO on March 1. The company announced Dec. 6 that Scott Wilkinson, currently president and COO, will succeed Ray Huggenberger, who is retiring. Wilkinson will also join Inogen’s board of directors effective Jan. 1, 2017.

Right man for the job

Things are lining up beautifully for VGM and HME, says new CEO
 - 
02/19/2016

WATERLOO, Iowa – Mike Mallaro knows that one of his biggest responsibilities as CEO of The VGM Group will be maintaining late founder Van Miller’s legacy.

Numotion names GE exec as new leader

 - 
07/29/2014

ROCKY HILL, Conn. – Numotion’s board of directors announced this week that Mike Swinford has taken over as CEO. Paul Bergantino, the company’s former CEO, will remain onboard as a consultant during the transition process, according to a press release.

Univita sells division, names new CEO

 - 
06/12/2014

EDEN PRAIRIE, Minn. – Univita Health has signed an agreement to sell its Insurance Administration Services division to Stone Point Capital, a private equity firm.

It’s official: Gaskins becomes CEO of United Spinal

 - 
06/10/2014

EAST ELMHURST, N.Y. – The United Spinal Association has named Joseph Gaskins its permanent president and CEO. Gaskins is an experienced Washington, D.C., lobbyist, accomplished executive in the wireless industry and wheelchair user from Seattle.

Harmar works way up food chain

‘If we continue to grow the business, there are going to be other funders,’ says new CEO
 - 
06/06/2014

SARASOTA, Fla. – Drew McCartney, Harmar’s new president and CEO, has made a career for himself shaking up the go-to market strategies of private equity backed healthcare companies.

New Rotech CEO talks strategy

 - 
04/18/2014

ORLANDO, Fla. – Rotech Healthcare is speeding up turnaround plans, with a new CEO and some “aggressive goals.”

ResMed details progress on new CEO, initiates dividend

 - 
05/22/2012

SAN DIEGO – Dr. Pete Farrell will remain CEO of ResMed until the end of the calendar year 2013, per the request of the manufacturer’s board of directors.

In the meantime, ResMed will continue to evaluate potential internal CEO candidates.